Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5061 USD | +12.47% | -.--% | +66.04% |
05-10 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
05-09 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company has insufficient levels of profitability.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 1310.04 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+66.04% | 48.2B | - | ||
+1.73% | 101B | A- | ||
-11.38% | 59.17B | A- | ||
+4.53% | 35.55B | B | ||
-0.16% | 30.82B | A- | ||
+1.99% | 18.43B | B- | ||
+18.42% | 17.68B | C+ | ||
+5.32% | 13.8B | B- | ||
-7.05% | 12.88B | B | ||
-27.52% | 11.94B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TPIA Stock
- PTPIF Stock
- Ratings PT Chandra Asri Pacific Tbk